AP NEWS

vTv Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference

November 19, 2018

HIGH POINT, N.C.--(BUSINESS WIRE)--Nov 19, 2018--vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that company management will present a corporate overview at the Piper Jaffray 30 th Annual Healthcare Conference on Tuesday, Nov. 27, 2018 at 2:10 p.m. ET in New York City.

A live webcast of the presentation can be accessed  here  and will be archived for 30 days following the presentation at  www.vtvtherapeutics.com.

vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflammatory disorders.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181119005483/en/

CONTACT: Investors:

vTv Therapeutics Inc.

IR@vtvtherapeutics.com

or

Media:

Josh Vlasto

212-572-5969

PR@vtvtherapeutics.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK NORTH CAROLINA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS MENTAL HEALTH PHARMACEUTICAL DIABETES

SOURCE: vTv Therapeutics Inc.

Copyright Business Wire 2018.

PUB: 11/19/2018 04:00 PM/DISC: 11/19/2018 04:01 PM

http://www.businesswire.com/news/home/20181119005483/en

AP RADIO
Update hourly